series C
![Agomab raises $100M to advance its Crohnâs disease drug candidate](https://pharmtales.com/wp-content/uploads/2023/10/Agomab-raises-100M-to-advance-its-Crohns-disease-drug-candidate.jpg)
Agomab raises $100M to advance its Crohnâs disease drug candidate
Anika Sharma
Agomab Therapeutics, in a remarkable stride forward, has secured an impressive $100 million in series C financing, just one week ...
![virtual incision mini-robot surgery, virtual incision funding series b+, virtual incision mira surgical platform, virtual incision laparoscopic surgery robot, virtual incision portable robot surgery, virtual incision fda approval status, virtual incision mini-robot benefits](https://pharmtales.com/wp-content/uploads/2023/09/Virtual-Incision-secures-30M-funding-to-expand-its-mini-robot-for-laparoscopic-surgery.jpg)
Virtual Incision secures $30M funding to expand its mini-robot for laparoscopic surgery
Anika Sharma
A diminutive robot is making a significant financial stride. Virtual Incision, a pioneer in assisted surgery technology, has secured a ...